Gary R. Braslawsky

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Purification and preferential synthesis of binding molecules
- Patent number 7,700,097
- Issue date Apr 20, 2010
- Biogen Idec MA Inc.
- Gary R. Braslawsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TAG-72 specific CH2 domain deleted antibodies
- Patent number 7,319,139
- Issue date Jan 15, 2008
- Biogen Idec, Inc.
- Gary R Braslawsky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Synergistic composition and methods for treating neoplastic or canc...
- Patent number 6,998,125
- Issue date Feb 14, 2006
- Biogen Idec Inc.
- Nabil Hanna
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Production of tetravalent antibodies
- Patent number 6,897,044
- Issue date May 24, 2005
- Biogen Idec, Inc.
- Gary R Braslawsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MODIFIED ANTIBODIES AND METHODS OF USE
- Publication number 20110020222
- Publication date Jan 27, 2011
- Biogen Idec MA Inc.
- Gary R. Braslawsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED ANTIBODIES AND METHODS OF USE
- Publication number 20090022658
- Publication date Jan 22, 2009
- Gary R. Braslawsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
- Publication number 20080213260
- Publication date Sep 4, 2008
- Biogen Idec Inc.
- Kandasamy Hariharan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
- Publication number 20080213167
- Publication date Sep 4, 2008
- Biogen Idec Inc.
- Kandasamy Hariharan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
- Publication number 20080213168
- Publication date Sep 4, 2008
- Biogen Idec Inc.
- Kandasamy Hariharan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
- Publication number 20080171056
- Publication date Jul 17, 2008
- Biogen Idec Inc.
- Kandasamy Hariharan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TAG-72 SPECIFIC CH2 DOMAIN DELETED ANTIBODIES
- Publication number 20070280881
- Publication date Dec 6, 2007
- Gary R. Braslawsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
- Publication number 20060286100
- Publication date Dec 21, 2006
- Biogen Idec Inc.
- Kandasamy Hariharan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
- Publication number 20060286101
- Publication date Dec 21, 2006
- Biogen Idec Inc.
- Kandasamy Hariharan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
- Publication number 20060171950
- Publication date Aug 3, 2006
- Biogen Idec Inc.
- Kandasamy Hariharan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Synergistic composition and methods for treating neoplastic or canc...
- Publication number 20060153848
- Publication date Jul 13, 2006
- Nabil Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Purification and preferential synthesis of binding molecules
- Publication number 20050163783
- Publication date Jul 28, 2005
- Biogen Idec MA Inc.
- Gary R. Braslawsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Production of tetravalent antibodies
- Publication number 20050158828
- Publication date Jul 21, 2005
- Biogen Idec, Inc.
- Gary R. Braslawsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Thiol-mediated drug attachment to targeting peptides
- Publication number 20050118099
- Publication date Jun 2, 2005
- Gary R. Braslawsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Synergistic composition and methods for treating neoplastic or canc...
- Publication number 20040137014
- Publication date Jul 15, 2004
- Biogen Idec Inc.
- Nabil Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of CD23 antagonists for the treatment of neoplastic disorders
- Publication number 20030211107
- Publication date Nov 13, 2003
- Kandasamy Hariharan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of CD23 antagonists for the treatment of neoplastic disorders
- Publication number 20020159996
- Publication date Oct 31, 2002
- Kandasamy Hariharan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Synergistic composition and methods for treating neoplastic or canc...
- Publication number 20010019715
- Publication date Sep 6, 2001
- IDEC Pharmaceuticals Corporation
- Nabil Hanna
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Synergistic composition and methods for treating neoplastic or canc...
- Publication number 20010018054
- Publication date Aug 30, 2001
- IDEC Pharmaceuticals Corporation
- Nabil Hanna
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Gary R. Braslawsky

Person

Patents Grantslast 30 patents

Purification and preferential synthesis of binding molecules

TAG-72 specific CH2 domain deleted antibodies

Synergistic composition and methods for treating neoplastic or canc...

Production of tetravalent antibodies

Patents Applicationslast 30 patents

MODIFIED ANTIBODIES AND METHODS OF USE

MODIFIED ANTIBODIES AND METHODS OF USE

USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS

USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS

USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS

USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS

TAG-72 SPECIFIC CH2 DOMAIN DELETED ANTIBODIES

Use of CD23 Antagonists for the Treatment of Neoplastic Disorders

Use of CD23 Antagonists for the Treatment of Neoplastic Disorders

USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS

Synergistic composition and methods for treating neoplastic or canc...

Purification and preferential synthesis of binding molecules

Production of tetravalent antibodies

Thiol-mediated drug attachment to targeting peptides

Synergistic composition and methods for treating neoplastic or canc...

Use of CD23 antagonists for the treatment of neoplastic disorders

Use of CD23 antagonists for the treatment of neoplastic disorders

Synergistic composition and methods for treating neoplastic or canc...

Synergistic composition and methods for treating neoplastic or canc...